USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
17-Jun-2021
North America
Market Research
MG0C-01-00-00-00
HC03420-NA-MT_25509
$4,950.00
Special Price $3,712.50 save 25 %
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as those of the pharmaceutical sponsors. The study segments the market by product (drug substance and drug product), cell line (mammalian, microbial, and viral vectors and other modalities) and service (clinical and commercial) types. The market forecasts in this report are for 2020–2026. They capture key market developments, such as capacity expansions, mergers, acquisitions, and expanding services offerings set to impact the overall bio-CDMO market growth.
Other discussions on the global bio-CDMO market include:
• Impact of strategic imperatives on the industry
• Growth drivers and restraints
• Comprehensive insights on its competitive landscape
• Revenue share estimates of top market participants
• A strategic analysis of market developments regarding services offerings and business models
• Growth opportunities centered on single-use technology in the development and manufacturing of personalized medicine, COVID-19 vaccine scale-up partnerships, assets co-development with small and midsize pharma companies, and opportunities in China’s domestic biopharma market
Author: Deepak Jayakumar
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Biologics Contract Development and Manufacturing Organizations Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Bio-CDMO Market Scope of Analysis
Bio-CDMO Market Segmentation by Product Type
Bio-CDMO Market Segmentation by Cell Line Type
Bio-CDMO Market Segmentation by Service Type
Key Competitors for the Bio-CDMO Market
Key Growth Metrics for the Global Bio-CDMO Market
Growth Drivers for Bio-CDMO Market
Growth Restraints for the Bio-CDMO Market
Forecast Framework, Bio-CDMO Market
Forecast Methodology, Bio-CDMO Market
Forecast Assumptions and Considerations, Bio-CDMO Market
Revenue Forecast, Bio-CDMO Market
Revenue Forecast Analysis, Bio-CDMO Market
Revenue Forecast by Product Type, Bio-CDMO Market
Revenue Forecast Analysis by Product Type, Bio-CDMO Market
Revenue Forecast by Cell Line Type, Bio-CDMO Market
Revenue Forecast Analysis by Cell Line Type, Bio-CDMO Market
Revenue Split by Service Type, Bio-CDMO Market
Revenue Forecast Analysis by Service Type, Bio-CDMO Market
Regional Analysis, Bio-CDMO Market
Competitive Environment, Bio-CDMO Market
Revenue Share, Bio-CDMO Market
Revenue Share Analysis, Bio-CDMO Market
Top Bio-CDMOs Edging Closer to a Comprehensive One-Stop-Shop Service Offering
Growth Avenues, Bio-CDMO Industry
Transitions in Bio-CDMO Business Models
Growth Opportunity Analysis Mapping, Bio-CDMO Market
Growth Opportunity 1—Adoption of Single-Use Technology for Cell and Gene Therapy Manufacturing
Growth Opportunity 1—Adoption of Single-Use Technology for Cell and Gene Therapy Manufacturing (continued)
Growth Opportunity 2—Capacity-Building Partnerships for COVID-19 Vaccine Manufacturing
Growth Opportunity 2—Capacity-Building Partnerships for COVID-19 Vaccine Manufacturing(continued)
Bio-CDMO Milestones for COVID-19 Vaccine Manufacturing
Growth Opportunity 3—Co-Developing Antibody Therapies with Clinical-stage Biopharma Companies
Growth Opportunity 3—Co-Developing Antibody Therapies with Clinical-stage Biopharma Companies (continued)
Growth Opportunity 4—Addressing Capacity Scale-up Needs of China’s Domestic Biopharma Market
Growth Opportunity 4—Addressing Capacity Scale-up Needs of China’s Domestic Biopharma Market (continued)
China’s Biologics Pipeline
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Deepak Jayakumar |
| Industries | Healthcare |
| WIP Number | MG0C-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,99C1-B1,9568-B1,9611-B1 |
